1-15 of 15
MHD Monzr M. Al Malki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Vs-Host Disease and Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation: A Case-Control Propensity Matching Analysis

Tamer Othman, Dongyun Yang, Sally Mokhtari, Ibrahim Aldoss, Geoffrey Shouse, Shukaib Arslan, Leonardo Farol, Leslie L. Popplewell, Ahmed Aribi, Alex F. Herrera, Lihua E. Budde, Joshua Mansour, Matthew Mei, Karamjeet S Sandhu, Tanya Siddiqi, Jasmine Zain, Vaibhav Agrawal, Idoroenyi Amanam, Vinod Pullarkat, Tycel J. Phillips, Ryotaro Nakamura, Stephen J. Forman, MHD Monzr M. Al Malki
Journal: Blood
Blood (2024) 144 (Supplement 1): 3534.
https://doi.org/10.1182/blood-2024-207125
Published: 2024
Journal Articles

Final Analysis of Phase 2a Study of Adding Itacitinib to Tacrolimus/Sirolimus Gvhd Prophylaxis after Fludarabine/Melphalan-Based Conditioning Hematopoietic Cell Transplantation for Acute Leukemias, Myelodysplastic Syndrome (MDS), or Myelofibrosis (MF)

Haris Ali, Dongyun Yang, NI-Chun Tsai, Sally Mokhtari, Tim W Synold, Idoroenyi Amanam, Andrew Artz, Peter T. Curtin, Karamjeet S Sandhu, Anthony S. Stein, Shukaib Arslan, Salman Otoukesh, Firoozeh Sahebi, Joshua Mansour, Paul B. Koller, Amandeep Salhotra, Ibrahim Aldoss, Vinod Pullarkat, Brian J. Ball, Stephen J. Forman, Guido Marcucci, MHD Monzr M. Al Malki, Ryotaro Nakamura
Journal: Blood
Blood (2024) 144 (Supplement 1): 1043.
https://doi.org/10.1182/blood-2024-206169
Published: 2024
Journal Articles

Superiority of Post-Transplant Cyclophosphamide-Based Graft Versus Host Disease (GvHD) Prophylaxis in Patients 70 Years and Older: A BMT CTN 1703 Post-Hoc Analysis

Sameem Abedin, Qinghua Lian, Michael J Martens, MHD Monzr M. Al Malki, Hany Elmariah, Mahasweta Gooptu, Karilyn T. Larkin, Brian C. Shaffer, Alison W Loren, Melhem M. Solh, Amin M. Alousi, Omer Jamy, Janny M. Yao, Kristy Applegate, Miguel Angel Perales, Leslie Kean, Yvonne A. Efebera, Ran Reshef, William Clark, Eric Leifer, Mary M. Horowitz, Richard J. Jones, Javier Bolanos-Meade, Shernan G. Holtan, Mehdi Hamadani
Journal: Blood
Blood (2024) 144 (Supplement 1): 1042.
https://doi.org/10.1182/blood-2024-193827
Published: 2024
Journal Articles

TP53 Mutations Increased the Risk of CD19 Negative Relapse Following Blinatumomab in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Ibrahim Aldoss, Jeffrey Li, Jianying Zhang, Mary C Clark, Vaibhav Agrawal, Hoda Pourhassan, Paul B. Koller, Ahmed Aribi, Haris Ali, Amanda Blackmon, Salman Otoukesh, Karamjeet S Sandhu, Brian J. Ball, Andrew Artz, Idoroenyi Amanam, MHD Monzr M. Al Malki, Amandeep Salhotra, Lindsey A. Murphy, Dat Ngo, Jose Tinajero, Zhaohui Gu, Pamela S. Becker, Ryotaro Nakamura, Anthony S. Stein, Guido Marcucci, Stephen J. Forman, Vinod Pullarkat
Journal: Blood
Blood (2024) 144 (Supplement 1): 729.
https://doi.org/10.1182/blood-2024-208674
Published: 2024
Journal Articles

OPTIMIZE: A Phase II Study of Reduced Dose Post Transplantation Cyclophosphamide As GVHD Prophylaxis in Adult Patients with Hematologic Malignancies Receiving HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Jeffery J. Auletta, Steven M. Devine, Heather E. Stefanski, Stephen R. Spellman, Todd E. Defor, Brent R. Logan, Brandan J. Butler, Mahasweta Gooptu, Brian C. Shaffer, Antonio M. Jimenez Jimenez, Sameem Abedin, Dipenkumar Modi, MHD Monzr M. Al Malki, Rachel J. Cook
Journal: Blood
Blood (2024) 144 (Supplement 1): 3514.1.
https://doi.org/10.1182/blood-2024-198252
Published: 2024
Journal Articles

Phase 1 Trial of Navitoclax/Venetoclax/Decitabine Combination in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Anthony S. Stein, Jianying Zhang, Lucy Y. Ghoda, Marjorie Robbins, Cindy Croslin, Banafsheh Sinaki, Ahmed Aribi, Amanda Blackmon, Hoda Pourhassan, Brian J. Ball, Ibrahim Aldoss, Ryotaro Nakamura, MHD Monzr M. Al Malki, Karamjeet S Sandhu, Guido Marcucci
Journal: Blood
Blood (2024) 144 (Supplement 1): 4264.
https://doi.org/10.1182/blood-2024-205980
Published: 2024
Journal Articles

WUN101-01: First in Human Human (FIH) Phase 1 Study of WU-NK-101 (W-NK1) in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Amanda F. Cashen, MHD Monzr M. Al Malki, Don A. Stevens, Lori Muffly, Natasha Edwin, Edward Abadir, Peter Tan, Sandrine Niyongere, Ashish Bajel, Laura Arthur, Nitin Mahajan, Ben Capoccia, Tom Leedom, Basia Muz, Kristann Magee, Ouiam Bakkacha, Justo L. Gonzalez, Deborah Masters, Stephen Moran, Eileen McNulty, Angela Pannunzio, Jayakumar Vadakekolathu, Tony Wu, Maria del Rosario, Preeta Dasgupta, Michael Munroe, Laura Simpson, Melissa M Berrien-Elliott, John Muth, Sergio Rutella, Jan K Davidson-Moncada, Todd A Fehniger
Journal: Blood
Blood (2024) 144 (Supplement 1): 4257.
https://doi.org/10.1182/blood-2024-201520
Published: 2024
Journal Articles

TSC-100 and TSC-101 Demonstrate the Potential to Reduce Relapse Rates and Increase Relapse-Free Survival in Patients with AML, ALL, or MDS Undergoing Allogeneic HCT with Reduced Intensity Conditioning (RIC): Preliminary Results from the Phase 1 Alloha Trial

MHD Monzr M. Al Malki, Alla Keyzner, Uday Popat, Yi-Bin Chen, Hyung C Suh, Tania Jain, Melhem M. Solh, Anson Snow, Saar Gill, Lohith Gowda, Joseph Uberti, Erica Buonomo, Yun Wang, Nancy Nabilsi, Timothy White, Cuong Nguyen, Jim Murray, Gavin MacBeath, Chrystal Louis, Shrikanta Chattopadhyay, Michelle Matzko, Ran Reshef
Journal: Blood
Blood (2024) 144 (Supplement 1): 924.
https://doi.org/10.1182/blood-2024-201526
Published: 2024
Journal Articles

Multidimensional Analysis of Relapsed Bone Marrow Reveals Cold Immune Microenvironment Post-TMLI in Acute Leukemia Transplant Patients

Srideshikan Sargur Madabushi, Ji Eun Lim, Yu-Lin SU, Paresh Vishwasrao, Dongyun Yang, James F. Sanchez, Sally Mokhtari, Amandeep Salhotra, Xiwei Wu, Haiqing Lee, Savita Dandapani, Ryotaro Nakamura, Raju Pillai, Marcin Kortylewski, Jeffrey Wong, MHD Monzr M. Al Malki, Anthony S. Stein, Susanta Hui
Journal: Blood
Blood (2024) 144 (Supplement 1): 775.
https://doi.org/10.1182/blood-2024-211180
Published: 2024
Journal Articles

A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Yesid Alvarado-Valero, Rachel J. Cook, Shira N. Dinner, Michael Keng, Kebede Begna, Sameem Abedin, MHD Monzr M. Al Malki, Vijaya Raj Bhatt, Nathalie Javidi-Sharifi, Prabhu Rajagopolan, Sandra Wiley, Richard G Ghalie, Matthew S. Davids
Journal: Blood
Blood (2024) 144 (Supplement 1): 2878.
https://doi.org/10.1182/blood-2024-198718
Published: 2024
Journal Articles

Tissue-Specific Myeloablative Conditioning with Total Marrow Irradiation Enhances Gut Microbiome Diversity and Mitigates Gvhd: A Novel Therapeutic Approach

Ji Eun Lim, Srideshikan Sargur Madabushi, Mengistu Lemecha Shukare, Hemendra Ghimire, Jenny Paredes, Sally Mokhtari, James F. Sanchez, Karamjeet S Sandhu, Amandeep Salhotra, Ryotaro Nakamura, Jeffrey Wong, Anthony S. Stein, Dorothy Schaue, Marcel R.M. van den Brink, MHD Monzr M. Al Malki, Guy Storme, Susanta Hui
Journal: Blood
Blood (2024) 144 (Supplement 1): 3393.
https://doi.org/10.1182/blood-2024-210774
Published: 2024
Journal Articles

Outcomes of Hypomethylating Agents/Venetoclax (HMA/VEN) Treatment for Relapse of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) after Allogeneic Hematopoietic Cell Transplant (alloHCT)

Diana T Samuels, Brian J. Ball, NI-Chun Tsai, Amanda Blackmon, Vaibhav Agrawal, Hoda Pourhassan, Idoroenyi Amanam, Paul B. Koller, Shukaib Arslan, Salman Otoukesh, Karamjeet S Sandhu, Ibrahim Aldoss, Haris Ali, Amandeep Salhotra, MHD Monzr M. Al Malki, Andrew Artz, Pamela S. Becker, Ahmed Aribi, Eileen Patricia Smith, Stephen J. Forman, Anthony S. Stein, Guido Marcucci, Ryotaro Nakamura, Vinod Pullarkat
Journal: Blood
Blood (2024) 144 (Supplement 1): 4935.
https://doi.org/10.1182/blood-2024-210956
Published: 2024
Journal Articles

Social Vulnerability Is an Important Predictor of Cardiovascular Disease Risk after Allogeneic Hematopoietic Cell Transplantation

Osariemen Ogiamien, Sitong Chen, MHD Monzr M. Al Malki, Andrew Artz, Liezl Atencio, Alysia Bosworth, Meagan Echevarria, Caitlyn Estrada, Mareen Kassabian, Lanie Lindenfeld, Ryotaro Nakamura, June-Wha Rhee, F. Lennie Wong, Saro Armenian, Rusha Bhandari
Journal: Blood
Blood (2024) 144 (Supplement 1): 4924.
https://doi.org/10.1182/blood-2024-203678
Published: 2024
Journal Articles

A Phase 2, Single-Arm, Multicohort, Open Label, Multicenter Trial of Off-the-Shelf Natural Killer Cells (SAR445419) in Patients with High-Risk Myeloid Malignancies Undergoing Allogeneic HSCT

MHD Monzr M. Al Malki, Melhem M. Solh, Anurag K. Singh, Rushang D. Patel, Denis-Claude Roy, Agata Drewniak, Gu Mi, Lorraine Tracey, Giovanni Abbadessa, Richard E. Champlin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4921.
https://doi.org/10.1182/blood-2023-173241
Published: 2023
Journal Articles

Haploidentical Donor Transplantation with Posttransplantation Cyclophosphamide in Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Institutional Collaboration of 14 Centers

Tania Jain, Hua-Ling Tsai, Hany Elmariah, Pankit Vachhani, Theodoros Karantanos, Sarah A Wall, Lukasz P. Gondek, Asad Bashey, Alla Keyzner, Michael R. Grunwald, Sameem Abedin, Kalyan VG Nadiminti, Madiha Iqbal, Aaron T. Gerds, Auro Viswabandya, Shannon R McCurdy, MHD Monzr M. Al Malki, Ravi Varadhan, Haris Ali, Vikas Gupta, Richard J. Jones, Salman Otoukesh
Journal: Blood
Blood (2022) 140 (Supplement 1): 7731–7733.
https://doi.org/10.1182/blood-2022-157985
Published: 2022